It is
an American action thriller film directed by Tony Gilroy (he has a post in my blog) and is the fourth installment in
the series of films adapted from the Jason Bourne novels originated by Robert Ludlum and continued by Eric Van Lustbader, being preceded by The Bourne
Identity (2002), The Bourne
Supremacy (2004), and The Bourne
Ultimatum (2007) (they have posts in my blog).
Although
this film has the same title as Van Lustbader's first Bourne novel, The Bourne
Legacy, the actual screenplay bears little resemblance to the novel. Unlike
the novel, which features Jason Bourne as the principal character, the film
centers on black ops agent Aaron Cross (played by Jeremy Renner -he has a post in my blog-), an original character. In
addition to Renner, the film stars Rachel Weisz (she has a post in my blog) and Edward Norton.
The
titular character Jason Bourne does not appear in The Bourne Legacy,
as actor Matt Damon (he has a post in my blog) chose not to return for the fourth
film, due to Paul Greengrass (he has a post in my blog) not directing. Bourne is shown in
pictures and mentioned by name several times throughout the film. Tony Gilroy,
co-screenwriter of the first three films, sought to continue the story of the
film series without changing its key events, and parts of The Bourne
Legacy take place at the same time as the previous film, The Bourne
Ultimatum (2007). Aaron Cross is a member of a black ops program called
Operation Outcome whose subjects are genetically enhanced. He must run for his
life once former CIA Treadstone agent Jason Bourne's actions lead to the public exposure
of Operation Treadstone and its successor Operation Blackbriar.
Filming
was primarily in New York City, with some scenes shot in the Philippines, South Korea, Pakistan, and Canada. Released on August 10,
2012, the film received mixed reviews, with critics praising the story, James
Newton Howard's score, and Renner's performance, but expressing disappointment
in Matt Damon's absence, as well as the lack of shaky camera work (a key element of Greengrass'
directorial style) that the second and third films had used. The film was
followed in 2016 by Jason Bourne, in which Damon and Greengrass
reprised their earlier roles.
Plot
Six
weeks after Jason Bourne's escape from Moscow in The Bourne Supremacy, Aaron Cross, an operative belonging to
a Department of Defense black ops program called Operation Outcome, is assigned to Alaska for a training exercise. He
is forced to survive weather extremes and traverse rugged terrain to arrive at
a remote cabin as punishment for missing training and going off the grid for
four days. The cabin is operated by an exiled Outcome operative, Number Three,
who informs Cross that he has broken the mission record by two days. As an
Outcome operative, Cross uses experimental pills known as "chems"
which enhance the physical and mental abilities of their users.
After
the Treadstone and Blackbriar programs are exposed, retired Air Force colonel Eric Byer is
tasked with containing the fallout. He discovers a potentially scandalous video
on the Internet showing a meeting between Treadstone and Outcome medical
directors. To prevent the Senate investigation from learning about Outcome,
Byer orders everyone associated with the program killed. He sees the sacrifice
as acceptable to protect next-generation "beta programs", including
the supersoldier program LARX.
Byer
deploys a drone to eliminate Outcome agents Number
Three and Five (Cross) in Alaska .
Cross evades the drone and force-feeds his radio-frequency identification to a wolf which is then
blown up by a missile, tricking Byer into believing Cross is dead. At
Sterisyn-Morlanta, a biogenetics company supporting Outcome, researcher Dr.
Donald Foite shoots and kills all but one of his colleagues in the research
laboratory. After being cornered by guards, Foite turns his gun on himself,
leaving biochemist Dr. Marta Shearing as the sole survivor. Other Outcome agents are
eliminated when their handlers give them poisoned yellow pills disguised as new
chems.
Four
"D-Trac" assassins disguised as federal agents visit Shearing at her
country house. When she states her belief of Foite having been chemically
brainwashed into an emotionless killer, the assassins attempt to fake her
suicide, but are killed by Cross. Shearing reveals that Cross has been genetically modified by a tailored virus to
retain the physical benefits permanently without needing the green chems
anymore. He still requires regular doses of blue chems to maintain his
intelligence, but he is running out. Cross confides to her that he is Private First Class Kenneth J. Kitsom (reportedly
killed by an improvised explosive device in the Iraq War) and that his recruiter added
twelve points to his IQ, enabling Cross to meet the United States Army's requirements. Without his enhanced intelligence, Cross
believes they stand no chance of survival. Cross and Shearing travel to Manila, where the chems are
manufactured, to try to infect him with another virus that will make his
intelligence permanent.
Cross
and Shearing bluff their way into the Morlanta Pacific pharmaceutical factory
and Shearing injects Cross with the live virus stems. Byer alerts factory
security, but they evade capture. Byer orders LARX-03, a chemically-brainwashed
supersoldier, to track and kill them. As Cross is struck by flu-like symptoms
induced by the virus, he hallucinates about his Outcome training. When police
surround their shelter while Shearing is buying medicine, Cross rescues her and
steals a motorbike. After a lengthy chase through the streets and marketplaces
of Manila to Marikina, they lose the police and kill
the assassin. Shearing persuades a Filipino boatman to help them escape by sea.
Back
in New York ,
Blackbriar supervisor Noah Vosen lies to the Senate, stating that Blackbriar
was created solely to track down Jason Bourne, and that Deputy Director Pamela Landy committed
treason by assisting Bourne and trying to sell Treadstone secrets to the press.
Box office
In
its opening weekend, The Bourne Legacy grossed about $38.7
million in the United States
and Canada
and debuted at #1 of the box office charts, surpassing Universal's expectation
of $35 million. It grossed $46.6 million worldwide in its first weekend. The
film sold roughly 400,000 more tickets on its opening weekend than the first
film in the series, The Bourne Identity. Studio research reported
that audiences were evenly mixed among the sexes. The film grossed
$113,203,870 in North America and $162,940,880
in foreign countries, bringing the film's worldwide total to $276,144,750.
Critical response
The
Bourne Legacy received
mixed reviews from critics. On Rotten Tomatoes the film has an approval
rating of 60% based on 219 reviews with an average rating of 5.9/10. The site's
critical consensus reads, "It isn't quite as compelling as the earlier
trilogy, but The Bourne Legacy proves the franchise has
stories left to tell—and benefits from Jeremy Renner's magnetic work in the
starring role." On Metacritic, the film has a score of 61 out
of 100 based on 42 critics, indicating "generally favorable reviews".
Audiences polled by CinemaScore gave the film an average
grade of "B" on an A+ to F scale.
Lisa Schwarzbaum of Entertainment Weekly gave the film an A-, commenting
that "Gilroy ,
who as a screenwriter has shaped the movie saga from the beginning, trades the
wired rhythms established in the past two episodes by Paul Greengrass for
something more realistic and closer to the ground. The change is refreshing.
Jason Bourne's legacy is in good hands." Roger Ebert of the Chicago Sun-Times gave the film 2½ stars out
of 4, writing: "The Bourne Legacy is always gripping in the
moment. The problem is in getting the moments to add up. I freely confess that
for at least the first 30 minutes I had no clear idea of why anything was
happening. The dialogue is concise, the cinematography is arresting and the
plot is a murky muddle."
Peter
Debruge of Variety wrote that "the combination of Robert Elswit's elegant
widescreen lensing and the measured editing by Tony Gilroy's brother John may
be easier to absorb than Greengrass' hyperkinetic docu-based style, but the
pic's convoluted script ensures that auds will emerge no less
overwhelmed." Michael Atkinson of The Village Voice also wrote a scathing review of
the film, saying: "The Bourne films have more than just
overstayed their welcome and outlasted the Ludlum books—they've been Van
Halenized,
with an abrupt change of frontman and a resulting dip in personality."
Kenneth Turan of the Los Angeles Times gave the film a positive review,
called the film "an exemplary espionage thriller that has a strong sense
of what it wants to accomplish and how best to get there." He especially
commended Gilroy 's work on the film: "Gilroy knows the
underpinnings of this world inside out and appreciates how essential it is to
maintain and extend the house style of cool and credible intelligence that
marked the previous films."
Todd McCarthy of The Hollywood Reporter commented on his review that
"the series' legacy is lessened by this capable but uninspired fourth
episode."
No hay comentarios:
Publicar un comentario
Los comentarios a esta entrada son moderados por Ángel Sancho Crespo, autor y administrador del blog